Ofatumumab: screen for hepatitis B virus before treatment

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
15 January 2014

Abstract

Patients with active infection with this virus should not be treated with ofatumumab.